Evidence map›Paper›PMID 33674836›Full record

ArticleThe international journal of neuropsychopharmacology2021

Repeated but Not Single Administration of Ketamine Prolongs Increases of the Firing Activity of Norepinephrine and Dopamine Neurons.

Chidiebere M Iro, Rami Hamati, Mostafa El Mansari, Pierre Blier

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. αJournal of psychopharmacology (Oxford, England) · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chidiebere M IroMood Disorders Research Unit, University of Ottawa Institute of Mental Health Research, Ottawa, Ontario, Canada.
Rami HamatiMood Disorders Research Unit, University of Ottawa Institute of Mental Health Research, Ottawa, Ontario, Canada.
Mostafa El MansariMood Disorders Research Unit, University of Ottawa Institute of Mental Health Research, Ottawa, Ontario, Canada.
Pierre BlierMood Disorders Research Unit, University of Ottawa Institute of Mental Health Research, Ottawa, Ontario, Canada.
University of Ottawa · CA

Funding

CIHR PJT-169078
6 · The paper itself

Abstract

backgroundClinical studies have shown that the rapid antidepressant effect of the glutamate N-methyl-D-aspartate receptor antagonist ketamine generally disappears within 1 week but can be maintained by repeated administration. Preclinical studies showed that a single ketamine injection immediately increases the firing and burst activity of norepinephrine (NE) neurons, but not that of serotonin (5-HT) neurons. It also enhances the population activity of dopamine (DA) neurons. In the present study, we investigated whether such alterations of monoamine neuronal firing are still present 1 day after a single injection, and whether they can be maintained by repeated injections.

methodsRats received a single ketamine injection or 6 over 2 weeks and the firing activity of dorsal raphe nucleus 5-HT, locus coeruleus NE, and ventral tegmental area DA neurons was assessed.

resultsOne day following a single injection of ketamine, there was no change in the firing activity of 5-HT, NE, or DA neurons. One day after repeated ketamine administration, however, there was a robust increase of the firing activity of NE neurons and an enhancement of burst and population activities of DA neurons, but still no change in firing parameters of 5-HT neurons. The increased activity of NE neurons was no longer present 3 days after the last injection, whereas that of DA neurons was still present. DA neurons were firing normally 7 days after repeated injections.

conclusionThese results imply that the enhanced activity of NE and DA neurons may play a significant role in the maintenance of the antidepressant action of ketamine.

Indexed as

Action PotentialsAdrenergic NeuronsAnimalsDopaminergic NeuronsExcitatory Amino Acid AntagonistsKetamineLocus CoeruleusMaleRaphe NucleiRatsRats, Sprague-DawleySerotonergic NeuronsTegmentum MesencephaliVentral Tegmental AreaExcitatory Amino Acid AntagonistsKetaminedepressiondopamineelectrophysiologyketaminenorepinephrineserotonin

Identifiers

PMID33674836
PMCPMC8299825
OpenAlexW3135551889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.